1. Home
  2. CREX vs ATNM Comparison

CREX vs ATNM Comparison

Compare CREX & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Creative Realities Inc.

CREX

Creative Realities Inc.

N/A

Current Price

$2.02

Market Cap

30.3M

Sector

Technology

ML Signal

N/A

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

N/A

Current Price

$1.32

Market Cap

31.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CREX
ATNM
Founded
N/A
2000
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.3M
31.4M
IPO Year
2015
2013

Fundamental Metrics

Financial Performance
Metric
CREX
ATNM
Price
$2.02
$1.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
★ $8.33
$4.00
AVG Volume (30 Days)
25.4K
★ 227.7K
Earning Date
11-16-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 14.17
EPS
N/A
★ 0.71
Revenue
★ $18,437,000.00
$90,000.00
Revenue This Year
$75.99
$38,788.89
Revenue Next Year
$13.27
N/A
P/E Ratio
★ N/A
$1.99
Revenue Growth
5.61
★ 11.11
52 Week Low
$2.00
$0.74
52 Week High
$4.42
$1.72

Technical Indicators

Market Signals
Indicator
CREX
ATNM
Relative Strength Index (RSI) 31.80 54.61
Support Level $2.00 $0.97
Resistance Level $2.36 $1.44
Average True Range (ATR) 0.12 0.13
MACD 0.01 -0.01
Stochastic Oscillator 22.89 28.97

Price Performance

Historical Comparison
CREX
ATNM

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The company operates in one reportable segment, marketing technology solutions. It offers solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks, along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media. Geographically, the company generates maximum revenue from the United States, and the rest from Canada.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

Share on Social Networks: